COUNCIL FOR RESPONSIBLE NUTRITION for COUNCIL FOR RESPONSIBLE NUTRITION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Monitored the NDAA for any issues related to the dietary supplements industry.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIA L GUSTAFSON | — |
| MICHAEL DAVID MEIROVITZ | — |
| STEVEN MISTER | — |
Taxation/Internal Revenue Code TAX
All legislative proposals related to the inclusion of dietary supplement purchases within tax-deductible Health Savings Accounts and Flexible Spending Accounts (HSAs/FSAs), including H.R. 4794, the Dietary Supplements Access Act and S.3172, A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products and foods for special dietary uses as qualified medical expenses.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIA L GUSTAFSON | — |
| MICHAEL DAVID MEIROVITZ | — |
| STEVEN MISTER | — |
Consumer Issues/Safety/Products CSP
Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Issues related to nutritional access for underserved populations. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. Issues related to proposed FDA reorganization. Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. General issues related to the dietary supplements industry.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIA L GUSTAFSON | — |
| MICHAEL DAVID MEIROVITZ | — |
| STEVEN MISTER | — |
Health Issues HCR
H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. Issues related to proposed FDA reorganization. General issues related to the dietary supplements industry.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIA L GUSTAFSON | — |
| MICHAEL DAVID MEIROVITZ | — |
| STEVEN MISTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.